Muscular Dystrophy
47
12
13
20
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
4.3%
2 terminated out of 47 trials
90.9%
+4.4% vs benchmark
2%
1 trials in Phase 3/4
15%
3 of 20 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 20 completed trials
Clinical Trials (47)
Evaluating a New Knee-Ankle-Foot Brace to Improve Gait in Children With Movement Disorders
Investigational Use of Neuromuscular Ultrasound
Amino Acids and Exercise in FSHD
Study of Inherited Neurological Disorders
iBCI Optimization for Veterans With Paralysis
A Study to Evaluate the Safety of AB-1003 (Previously LION-101) in Subjects With Genetic Confirmation of LGMD2I/R9 (Part1)
Assessment of a Portable Digital Device for Quantified Analysis of Markerless Walking in Volunteers With Neuromuscular Diseases or Asymptomatic Volunteers
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
Clinical Trial Readiness Network FSHD France: Prospective 24 Months MRI Study
Evaluating Long-term Use of a Pediatric Robotic Exoskeleton (P.REX/Agilik) to Improve Gait in Children With Movement Disorders
Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry
Genetics of Cardiovascular and Neuromuscular Disease
Clinical Trial Readiness for the Dystroglycanopathies
Vasodilator and Exercise Study for DMD (VASO-REx)
Follow-up Study on Female Carriers With DMD Gene Variants
Nomad P-KAFO Study
Effectiveness of 5-week Digital Respiratory Practice in Children With Duchenne and Becker Muscular Dystrophies.
Genetics of Pediatric-Onset Motor Neuron and Neuromuscular Diseases
Genetic Study of Familial and Sporadic ALS/Motor Neuron Disease, Miyoshi Myopathy and Other Neuromuscular Disorders
WREX Outcome Study